Atorvastatin in Active Vitiligo

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

December 31, 2017

Conditions
Vitiligo
Interventions
DRUG

Atorvastatin

The patients will be treated with the combination of oral atorvastatin and NBUVB phototherapy twice a week for 6 months. The initial starting dose of the oral atorvastatin will be 40mg daily and after 1 month, if tolerated clinically and biologically following blood tests, the dose will be increased to 80mg daily.

OTHER

UVB

The patients will be receiving only NB-UVB phototherapy twice a week for 6 months.

Trial Locations (2)

308205

National Skin center - 1 Mandalay Rd, Bedok

06001

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02432534 - Atorvastatin in Active Vitiligo | Biotech Hunter | Biotech Hunter